Search results for

Nearly 6,000 original stories were submitted to this round of Three-Minute Fiction. We're on the quest to select just one winner. Until then, we'll be reading a few of the stories that catch our eyes. To see these stories and others go to npr.org/threeminutefiction.

The United States — at more than 109,000 — accounts for more than a quarter of global deaths from COVID-19. More than 6.9 million worldwide have been infected with the coronavirus.

The $3.7 billion NBA franchise and a handful of businesses are returning money they received from a federal program that was intended to help small companies hurt by the coronavirus pandemic.

President Trump's 2020 budget proposal, released on Monday, calls for $8.6 billion in new border wall funding, along with increased military spending and deep cuts to domestic programs.

A new study says the current climate crisis is a "severe threat" to the safety of younger generations, who will experience far more extreme climate events such as heat waves, wildfires and floods.

The 229-202 vote in the Democratic-controlled chamber was largely along party lines, with nine GOP members joining Democrats. What happens next is up to the Justice Department.

New York’s more than $2 billion rental assistance program is nearly gone. In Western New York, new applications only in Erie and Niagara counties are likely to be funded.

At the tennis tournament this year, as in years past, a Harris hawk named Rufus has been soaring above the stadium. His job is to keep pigeons from trespassing onto the iconic grass on Centre Court.

The canal is being widened to handle much larger ships. But after five years of building, the project is expected to cost at least $1.6 billion more than planned. The builders and the canal operators both say the other side should pay.

A small Canadian firm takes on two of the largest drug companies in the world with its surprise launch of a generic copy of the best-selling blood thinner Plavis. Apotex began shipping its generic version to U.S. stores today. The makers of Plavix sold $6 billion of the popular heart drug last year.